PLEASANTON, CA--(Marketwire - December 19, 2007) - Lipid Sciences, Inc. (NASDAQ: LIPD) announced today the conclusion of enrollment of new patients in the Company’s HDL Therapy Clinical Trial currently being conducted at the Washington Hospital Center, Suburban Hospital, and Washington Adventist Hospital.
